Orphazyme AS (OCSE:ORPHA) Days Sales Outstanding : 0.00 (As of Jun. 2022)

View and export this data going back to 2017. Start your Free Trial

What is Orphazyme AS Days Sales Outstanding?

Orphazyme AS's average Accounts Receivable for the six months ended in Jun. 2022 was kr26.52 Mil. Orphazyme AS's Revenue for the six months ended in Jun. 2022 was kr0.00 Mil.

The historical rank and industry rank for Orphazyme AS's Days Sales Outstanding or its related term are showing as below:

OCSE:ORPHA's Days Sales Outstanding is not ranked ^*
in the Biotechnology industry.
Industry Median: 72.43
* Ranked among companies with meaningful Days Sales Outstanding only.

Orphazyme AS's Days Sales Outstanding stayed the same from Jun. 2021 (0.00) to Jun. 2022 (0.00).

Orphazyme AS Days Sales Outstanding Historical Data

The historical data trend for Orphazyme AS's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Orphazyme AS Days Sales Outstanding Chart

Orphazyme AS Annual Data

Trend

Jun14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Days Sales Outstanding

Get a 7-Day Free Trial

295.16

Orphazyme AS Semi-Annual Data
	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22
Days Sales Outstanding	Get a 7-Day Free Trial									-	-	-	140.11	-

Competitive Comparison of Orphazyme AS's Days Sales Outstanding

For the Biotechnology subindustry, Orphazyme AS's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Orphazyme AS's Days Sales Outstanding Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Orphazyme AS's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where Orphazyme AS's Days Sales Outstanding falls into.

Orphazyme AS Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

Orphazyme AS's Days Sales Outstanding for the fiscal year that ended in Dec. 2021 is calculated as

	Days Sales Outstanding (A: Dec. 2021 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Dec. 2020 )	+	Accounts Receivable (A: Dec. 2021 ))	/	count )	/	Revenue (A: Dec. 2021 )	*	Days in Period
=	( (0	+	29.268)	/	1 )	/	36.193	*	365
=	29.268					/	36.193	*	365
=	295.16

Orphazyme AS's Days Sales Outstanding for the quarter that ended in Jun. 2022 is calculated as:

	Days Sales Outstanding (Q: Jun. 2022 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Dec. 2021 )	+	Accounts Receivable (A: Jun. 2022 ))	/	count )	/	Revenue (A: Jun. 2022 )	*	Days in Period
=	( (29.268	+	23.765)	/	2 )	/	0	*	365 / 2
=	26.5165					/	0	*	365 / 2
=	N/A

Orphazyme AS (OCSE:ORPHA) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.

Orphazyme AS Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of Orphazyme AS's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.

Orphazyme AS (OCSE:ORPHA) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Orphazyme AS (OCSE:ORPHA) » Definitions » Days Sales Outstanding

Comparable Companies

Traded in Other Exchanges

N/A

Address

Ole Maaloes Vej 3, Copenhagen, DNK, DK-2200

Website

https://www.orphazyme.com

Orphazyme AS is a late-stage biopharmaceutical company engaged in the development and commercialization of novel therapeutics for the treatment of neurodegenerative rare diseases. The company's lead candidate, Arimoclomol, is in development for severe orphan diseases: Niemann-Pick disease Type C (NPC), Amyotrophic Lateral Sclerosis (ALS), and Inclusion Body Myositis (IBM).

Orphazyme AS (OCSE:ORPHA) Headlines

No Headlines